Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy (vol 8, 586, 2017)

被引：0
|
作者：
Guerzoni, Simona [1 ]
Pellesi, Lanfranco [1 ]
Baraldi, Carlo [1 ]
Cainazzo, Michela Maria [1 ]
Negro, Andrea [2 ]
Martelletti, Paolo [2 ]
Pini, Luigi Alberto [1 ,3 ]
机构：
[1] Univ Modena & Reggio Emilia, Policlin Hosp, Dept Diagnost Med Clin & Publ Hlth, Headache & Drug Abuse Res Ctr, Modena, Italy
[2] Sapienza Univ, St Andrea Hosp, Dept Clin & Mol Med, Reg Referral Headache Ctr, Rome, Italy
[3] Univ Modena & Reggio Emilia, Ctr Neurosci & Neurotechnol, Dept Biomed Metab & Neural Sci, Modena, Italy
来源：
FRONTIERS IN NEUROLOGY | 2018年 / 9卷
关键词：
chronic migraine; OnabotulinumtoxinA; long-term treatment; quality of life; tolerance; headache; medication overuse headache;
D O I：
10.3389/fneur.2018.00641
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 35 条
  • [1] Long-term Treatment Benifits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
    Guerzoni, Simona
    Pellesi, Lanfranco
    Baraldi, Carlo
    Cainazzo, Michela Maria
    Negro, Andrea
    Martelletti, Paolo
    Pini, Luigi Alberto
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [2] Long-term effectiveness of eptinezumab in treatment of patients with chronic migraine and medication-overuse headache
    Blumenfeld, A.
    Kudrow, D.
    McAllister, P.
    Boserup, L.
    Hirman, J.
    Cady, R.
    HEADACHE, 2023, 63 : 145 - 145
  • [3] Long-term effectiveness of eptinezumab in treatment of patients with chronic migraine and medication-overuse headache
    Blumenfeld, A.
    Kudrow, D.
    McAllister, P.
    Boserup, L.
    Hirman, J.
    Cady, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 375 - 376
  • [4] Long-term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication-overuse headache
    Blumenfeld, Andrew
    Kudrow, David
    Mcallister, Peter
    Boserup, Line Pickering
    Hirman, Joe
    Cady, Roger
    HEADACHE, 2024, 64 (07): : 738 - 749
  • [5] The Long-Term Efficacy and Safety of OnabotulinumtoxinA for the Prevention of Chronic Migraine in Patients with Medication Overuse: Results of the COMPEL Study
    Tepper, S. J.
    Wilson, M.
    Orejudos, A.
    Adams, Manack A.
    Blumenfeld, A.
    HEADACHE, 2018, 58 : 93 - 94
  • [6] The long-term efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine in patients with medication overuse: results of the COMPEL study
    Tepper, S.
    Wilson, M. -C.
    Orejudos, A.
    Adams, A. Manack
    Blumenfeld, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 78 - 78
  • [7] Long-term Efficacy of Erenumab in Chronic Migraine Patients with Acute Medication Overuse
    Tepper, S. J.
    Lipton, R. B.
    Silberstein, S. D.
    Kudrow, D.
    Ashina, M.
    Dodick, D. W.
    Zhang, F.
    Cheng, S.
    Mikol, D. D.
    HEADACHE, 2018, 58 (08): : 1298 - 1300
  • [8] Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment
    Vikelis, Michail
    Argyriou, Andreas A.
    Dermitzakis, Emmanouil V.
    Spingos, Konstantinos C.
    Makris, Nikolaos
    Kararizou, Evangelia
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [9] Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment
    Michail Vikelis
    Andreas A. Argyriou
    Emmanouil V. Dermitzakis
    Konstantinos C. Spingos
    Nikolaos Makris
    Evangelia Kararizou
    The Journal of Headache and Pain, 2018, 19
  • [10] Short-term efficacy of mindfulness added to treatment as usual for patients with chronic migraine and medication overuse headache
    Leonardi, Matilde
    Marcassoli, Alessia
    Sismondo, Pietro
    Curatoli, Chiara
    Lanza, Martina
    Barbadoro, Filippo
    Camarda, Giorgia
    Mazzucchelli, Alessia
    Montisano, Danilo
    D'Amico, Domenico
    Grazzi, Licia
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
1234